Key result
Catheter ablation has become first-line therapy for many tachycardias, though treating persistent atrial fibrillation and ventricular tachycardia in structural heart disease remains challenging.
Why the study?
Does catheter ablation therapy improve outcomes in patients with cardiac arrhythmias?
Does catheter ablation therapy improve outcomes in patients with cardiac arrhythmias?
Catheter ablation is an established first-line therapy for many arrhythmias, but challenges remain for persistent AF and VT in structural heart disease.
Answers are grounded in this paper and cite their sources.
Supports ablation as first-line for amenable tachycardias; leaves open better strategies for persistent AF and structural VT.
SUMMARY Techniques for catheter ablation of cardiac arrhythmias have evolved considerably since their introduction into clinical practice 30 years ago. Catheter ablation has become the first-line therapy for many types of tachycardia, but the treatment of persistent atrial fibrillation and ventricular tachycardia in patients with structural heart disease remains challenging. New technologies and hybrid therapies have been introduced to further improve outcomes and effectiveness.
No takes yet. Share an insight, caveat, or question.
Pison et al. (2013) conducted a review in Cardiac arrhythmias. Catheter ablation was evaluated. Catheter ablation has become first-line therapy for many tachycardias, though treating persistent atrial fibrillation and ventricular tachycardia in structural heart disease remains challenging.
Synapse has enriched 10 related papers. Consider them for comparative context: